1n46

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1n46" size="450" color="white" frame="true" align="right" spinBox="true" caption="1n46, resolution 2.20&Aring;" /> '''CRYSTAL STRUCTURE O...)
Line 1: Line 1:
-
[[Image:1n46.gif|left|200px]]<br />
+
[[Image:1n46.gif|left|200px]]<br /><applet load="1n46" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1n46" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1n46, resolution 2.20&Aring;" />
caption="1n46, resolution 2.20&Aring;" />
'''CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC'''<br />
'''CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC'''<br />
==Overview==
==Overview==
-
In this communication, we wish to describe the discovery of a novel series, of 6-azauracil-based thyromimetics that possess up to 100-fold, selectivities for binding and functional activation of the beta(1)-isoform, of the thyroid receptor family. Structure-activity relationship studies on, the 3,5- and 3'-positions provided compounds with enhanced TR beta, affinity and selectivity. Key binding interactions between the 6-azauracil, moiety and the receptor have been determined through of X-ray, crystallographic analysis.
+
In this communication, we wish to describe the discovery of a novel series of 6-azauracil-based thyromimetics that possess up to 100-fold selectivities for binding and functional activation of the beta(1)-isoform of the thyroid receptor family. Structure-activity relationship studies on the 3,5- and 3'-positions provided compounds with enhanced TR beta affinity and selectivity. Key binding interactions between the 6-azauracil moiety and the receptor have been determined through of X-ray crystallographic analysis.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1N46 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with PFA as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1N46 OCA].
+
1N46 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=PFA:'>PFA</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1N46 OCA].
==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Ammirati, M.J.]]
+
[[Category: Ammirati, M J.]]
[[Category: Chiang, P.]]
[[Category: Chiang, P.]]
-
[[Category: Chrunyk, B.A.]]
+
[[Category: Chrunyk, B A.]]
[[Category: Cornelius, P.]]
[[Category: Cornelius, P.]]
[[Category: DaSilva-Jardine, P.]]
[[Category: DaSilva-Jardine, P.]]
-
[[Category: Danley, D.E.]]
+
[[Category: Danley, D E.]]
-
[[Category: Dow, R.L.]]
+
[[Category: Dow, R L.]]
-
[[Category: Hank, R.F.]]
+
[[Category: Hank, R F.]]
-
[[Category: Hargrove, D.M.]]
+
[[Category: Hargrove, D M.]]
-
[[Category: LeMotte, P.K.]]
+
[[Category: LeMotte, P K.]]
[[Category: Lee, E.]]
[[Category: Lee, E.]]
-
[[Category: Newsome, W.P.]]
+
[[Category: Newsome, W P.]]
-
[[Category: Paight, E.S.]]
+
[[Category: Paight, E S.]]
[[Category: Pandit, J.]]
[[Category: Pandit, J.]]
-
[[Category: Patterson, T.A.]]
+
[[Category: Patterson, T A.]]
-
[[Category: Rosner, M.H.]]
+
[[Category: Rosner, M H.]]
-
[[Category: Schneider, S.R.]]
+
[[Category: Schneider, S R.]]
-
[[Category: Schulte, G.K.]]
+
[[Category: Schulte, G K.]]
-
[[Category: Simons, S.P.]]
+
[[Category: Simons, S P.]]
[[Category: Spitzer, J.]]
[[Category: Spitzer, J.]]
-
[[Category: Swick, A.G.]]
+
[[Category: Swick, A G.]]
-
[[Category: Tate, B.F.]]
+
[[Category: Tate, B F.]]
[[Category: PFA]]
[[Category: PFA]]
[[Category: transcription]]
[[Category: transcription]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:17:35 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:02:07 2008''

Revision as of 12:02, 21 February 2008


1n46, resolution 2.20Å

Drag the structure with the mouse to rotate

CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC

Contents

Overview

In this communication, we wish to describe the discovery of a novel series of 6-azauracil-based thyromimetics that possess up to 100-fold selectivities for binding and functional activation of the beta(1)-isoform of the thyroid receptor family. Structure-activity relationship studies on the 3,5- and 3'-positions provided compounds with enhanced TR beta affinity and selectivity. Key binding interactions between the 6-azauracil moiety and the receptor have been determined through of X-ray crystallographic analysis.

Disease

Known diseases associated with this structure: Thyroid hormone resistance OMIM:[190160], Thyroid hormone resistance, autosomal recessive OMIM:[190160]

About this Structure

1N46 is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics., Dow RL, Schneider SR, Paight ES, Hank RF, Chiang P, Cornelius P, Lee E, Newsome WP, Swick AG, Spitzer J, Hargrove DM, Patterson TA, Pandit J, Chrunyk BA, LeMotte PK, Danley DE, Rosner MH, Ammirati MJ, Simons SP, Schulte GK, Tate BF, DaSilva-Jardine P, Bioorg Med Chem Lett. 2003 Feb 10;13(3):379-82. PMID:12565933

Page seeded by OCA on Thu Feb 21 14:02:07 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools